Fmr LLC Sells 43,044 Shares of National Health Investors, Inc. (NYSE:NHI)

FMR LLC lowered its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 94.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,653 shares of the real estate investment trust's stock after selling 43,044 shares during the period. FMR LLC's holdings in National Health Investors were worth $223,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of NHI. Assetmark Inc. lifted its stake in National Health Investors by 27.8% during the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock valued at $54,000 after acquiring an additional 141 shares in the last quarter. Aviance Capital Partners LLC boosted its holdings in National Health Investors by 6.2% during the third quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust's stock worth $318,000 after purchasing an additional 221 shares during the last quarter. Arizona State Retirement System grew its position in National Health Investors by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust's stock worth $823,000 after purchasing an additional 222 shares in the last quarter. Covestor Ltd grew its holdings in shares of National Health Investors by 2,700.0% in the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock valued at $35,000 after acquiring an additional 405 shares in the last quarter. Finally, Van ECK Associates Corp grew its stake in National Health Investors by 6.9% in the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust's stock valued at $434,000 after purchasing an additional 416 shares during the period. Institutional investors own 62.51% of the company's stock.

Analyst Ratings Changes

NHI has been the subject of several research reports. Truist Financial increased their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 30th. Wells Fargo & Company downgraded National Health Investors from an "overweight" rating to an "equal weight" rating and upped their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. StockNews.com lowered National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Finally, Bank of America began coverage on National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, National Health Investors has an average rating of "Moderate Buy" and an average target price of $76.33.

National Health Investors Price Performance

NYSE NHI traded up $1.01 on Friday, hitting $69.85. The stock had a trading volume of 750,877 shares, compared to its average volume of 204,402. The firm has a 50-day moving average of $76.02 and a 200-day moving average of $75.60. The company has a market capitalization of $3.17 billion, a price-to-earnings ratio of 24.00, a price-to-earnings-growth ratio of 4.86 and a beta of 1.04. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors, Inc. has a 52-week low of $51.59 and a 52-week high of $86.13.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. National Health Investors's quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.08 EPS. Equities analysts expect that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 5.15%. The ex-dividend date is Tuesday, December 31st. National Health Investors's dividend payout ratio (DPR) is currently 123.71%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.